Estee Lauder Companies Inc header image

Estee Lauder Companies Inc

EL

Equity

ISIN null / Valor 99350

New York Stock Exchange, Inc (2025-11-19)
USD 85.91-2.44%

Estee Lauder Companies Inc
UMushroom community rating:

star star star star star
4.39 4 votes No rating yet
NegativeNeutralPositive

About company

Estee Lauder Companies Inc is a global prestige beauty company that owns and operates a portfolio of iconic beauty brands, including Le Labo, Dr.Jart+, Origins, AERIN Beauty, M·A·C, and Bobbi Brown Cosmetics. These brands offer a wide range of high-quality skincare, makeup, and fragrance products that cater to different consumer preferences and needs. With a focus on innovation, quality ingredients, and sustainability, Estee Lauder Companies Inc has established itself as a leader in the beauty industry, delivering products that empower individuals to enhance their natural beauty and feel confident in their own skin.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (11.11.2025):

Estee Lauder Companies Inc’s fiscal 2025 financial results show mixed outcomes. For the full fiscal year ending in 2025 – with notable fourth‐quarter highlights – reported and organic net sales declined by 8% compared to fiscal 2024. While adjusted gross margins improved to 74.0% driven by operational efficiencies and strategic pricing initiatives, the company experienced significant pressure on operating performance. GAAP operating results turned into a loss, and adjusted operating income slipped by 28%, reflecting higher restructuring, impairment, and litigation settlement charges. Additionally, operating cash flows and dividend payouts were reduced, even as the company continued investing in innovative product launches and geographic expansion to secure share gains in key markets.

Net Sales & Margins

Fiscal 2025 saw Estee Lauder Companies Inc’s reported and organic net sales decline by 8% compared to the prior year. Notably, the adjusted gross margin expanded to 74.0% from 71.7%, mainly due to the benefits from the company’s Profit Recovery and Growth Plan (PRGP) through cost efficiencies and strategic pricing actions.

Operating Performance & Earnings

The year’s operating performance was impacted by significant charges. GAAP operating income turned into a loss of $785 million compared to a prior gain, while adjusted operating income fell 28% to $1,146 million. Similarly, diluted net earnings per share reflected a dramatic decline, with GAAP earnings turning to a net loss of $(3.15) and adjusted diluted earnings decreasing to $1.51 from $2.59.

Cash Flows & Capital Investments

Estee Lauder Companies Inc reported a reduction in net cash flows from operating activities, down to $1.27 billion from $2.36 billion, influenced by lower pre-tax earnings and increased restructuring payments. Capital expenditures were also optimized, dropping to $602 million compared to $919 million, as the company focused on improving free cash flow, which was accompanied by a reduction in dividend payments.

Strategic & Operational Initiatives

Despite the financial headwinds, the company maintained a robust pipeline of beauty and operational initiatives. Fiscal 2025 accounted for several successful product launches and market expansions, with notable share gains in key regions such as mainland China, Japan, and the U.S. Enhancements in distribution channels and increased consumer-facing investments underline Estee Lauder Companies Inc’s commitment to rebuilding sales growth and operational profitability heading into fiscal 2026.

Summarized from source with an LLMView Source

Key figures

32.6%1Y
-63.2%3Y
-64.5%5Y

Performance

49.4%1Y
46.3%3Y
41.5%5Y

Volatility

Market cap

20173 M

Market cap (USD)

Daily traded volume (Shares)

3,513,521

Daily traded volume (Shares)

1 day high/low

74.62 / 72.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.39

4 votes
Performance:
starstarstarstarstar
3.78
Innovation:
starstarstarstarstar
3.67
Society:
starstarstarstarstar
3.83
Nature:
starstarstarstarstar
3.83
Sammy Siagos
United Kingdom, 24 Oct 2025
star star star star star
decent
Charles Davis
United Kingdom, 22 Oct 2025
star star star star star
Recent restructuring + focus on digital transformation
Giorgi Vancko
Switzerland, 19 Oct 2025
star star star star star
Company restructuring - posed for growth IMO.

EQUITIES OF THE SAME SECTOR

Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%EUR 9.03
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%EUR 35.30
Sartorius Stedim Biotech
Sartorius Stedim Biotech Sartorius Stedim Biotech Valor: 32518471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%EUR 185.00
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.15%EUR 14.12
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%SEK 282.60
Essity AB
Essity AB Essity AB Valor: 36846754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.39%SEK 257.50
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.54%SEK 342.60
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%CHF 3.25
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%CHF 70.10
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%EUR 13.01